ANCA Vasculitis News
Recent Posts
- Lower glucocorticoid dosing regimen may be risky, study finds December 18, 2024
- Q32 Bio pushes back Phase 2 trial of ADX-097 in AAV patients December 16, 2024
- Enrollment open for trial testing NKX019 cell therapy in AAV December 11, 2024
- EGPA should be considered in patients with severe asthma: Study December 9, 2024
- Frail ANCA-associated vasculitis patients at more risk of infection December 4, 2024
- Respiratory manifestations common, recurrent in pediatric GPA November 27, 2024
- Variants in SERPINA1 gene may increase risk of death in AAV November 25, 2024
- Rituximab found as effective as cyclophosphamide in AAV children November 20, 2024
- Higher risk of thyroid disease seen with ANCA-associated vasculitis November 18, 2024
- Blood GFAP levels linked to AAV disease activity, kidney involvement November 13, 2024